Skip to main content

Table 4 The associations of PMN elastase and ENR with autoantibodies in myositis patients

From: Correlation of PMN elastase and PMN elastase-to-neutrophil ratio with disease activity in patients with myositis

 

IIMs

P value

DM

P value

PM

P value

P/N

%

PMN elastase

ENR

P/N

%

PMN elastase

ENR

P/N

%

PMN elastase

ENR

ANA

63/7

90.0

0.619

0.724

47/7

87.0

0.413

0.489

16/0

100

Anti-Ro-52

41/33

55.4

0.732

0.511

28/30

48.3

0.250

0.109

13/3

81.3

0.638

0.545

Anti-Jo-1

15/59

20.3

0.633

0.386

7/51

12.1

0.072

0.467

8/8

100

0.916

0.401

Anti-PM-Scl

8/66

10.8

0.007

0.001

8/50

16.0

0.013

0.001

0/16

0

Anti-MDA5

21/53

28.4

0.619

0.385

21/37

36.2

0.289

0.740

0/16

0

Anti-Mi-2

11/63

14.9

0.184

0.074

11/47

19.0

0.326

0.124

0/16

0

Anti-TIF-1γ

14/60

18.9

0.649

0.610

12/46

20.1

0.618

0.420

2/14

12.5

0.056

0.056

Anti-NXP2

4/70

5.4

0.830

0.793

3/55

5.2

0.352

0.562

1/15

6.3

0.159

0.159

Anti-PL7

4/70

5.4

0.056

0.054

4/54

6.9

0.08

0.07

0/16

0

Anti-Ku

2/72

2.7

0.334

0.443

1/57

1.7

0.179

0.16

1/15

6.3

0.745

0.745

Anti-EJ

4/70

5.4

0.304

0.189

1/57

1.7

0.128

0.269

3/13

18.8

0.737

0.946

Anti-SAE1

3/71

4.1

0.184

0.064

3/55

5.2

0.136

0.056

0/16

0

Anti-SRP

3/71

4.1

0.077

0.150

1/57

1.7

0.324

0.570

2/14

12.5

0.266

0.266

  1. ANA antinuclear antibody, ENR PMN elastase-to-netrophil ratio